Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1605786A for Maintenance of Remission in Crohn's Disease
NCT01316939Phase 3Terminated
- Sponsor
- GSK
- Start
- May 2011
- Primary completion
- Oct 2013
- Countries
- 33
01
Overview
A Phase 3 trial of vercirnon in Crohn's disease, sponsored by GSK. Started May 2011; status: terminated.
02
Drugs
vercirnon
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01316939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316939.